← SELECT MEDICAL HOLDINGS CORP
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income From Continuing Operations | — | — | — | — | — | — | $198.0m | $299.7m | $296.7m | $214.5m | |
| Net Income (Loss) Attributable to Parent | $115.4m | $177.2m | $137.8m | $148.4m | $259.0m | $402.2m | $159.0m | $243.5m | $214.0m | $146.2m | |
| Net Income (Loss) Available to Common Stockholders, Basic | $111.9m | $171.4m | $133.3m | $143.5m | $250.1m | $388.8m | $153.4m | $234.7m | $296.7m | $214.5m | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $125.3m | $220.6m | $176.9m | $201.0m | $344.6m | $499.9m | $198.0m | $299.7m | $296.7m | $214.5m | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | — | — | $65.5m | $146.2m | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | $130.0m | $214.5m | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | $166.7m | $0 | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | — | — | $148.6m | $0 | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $9.9m | $43.5m | $39.1m | $52.6m | $85.6m | $97.7m | $39.0m | $56.2m | $82.7m | $68.3m | |
| Depreciation and amortization | $145.3m | $160.0m | $201.7m | $212.6m | $205.7m | $202.6m | $205.8m | $208.7m | $203.9m | $140.3m | |
| Depreciation | $129.0m | $142.6m | $171.7m | $182.9m | $178.0m | $173.2m | $174.8m | $177.1m | $141.1m | $138.5m | |
| Amortization of Debt Issuance Costs and Discounts | $15.7m | $11.1m | $13.1m | $11.6m | $2.2m | $2.2m | $2.3m | $2.6m | $3.0m | $3.1m | |
| Amortization of Intangible Assets | — | — | — | $29.6m | $27.6m | $29.5m | $31.0m | $31.7m | $1.6m | $1.6m | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $205.8m | $208.7m | $203.9m | $140.3m | |
| Deferred Income Tax Expense (Benefit) | ($12.6m) | ($72.3m) | $7.2m | ($7.4m) | ($14.7m) | $5.1m | $7.5m | ($16.1m) | ($30.9m) | $30.7m | |
| Deferred Income Tax | — | — | — | — | — | — | $7.5m | ($16.1m) | ($32.4m) | $30.7m | |
| Deferred Tax | — | — | — | — | — | — | $7.5m | ($16.1m) | ($32.4m) | $30.7m | |
| Share-based Payment Arrangement, Noncash Expense | $17.4m | $19.3m | $23.3m | $26.5m | $27.2m | $30.9m | $37.8m | $43.8m | $100.7m | $16.7m | |
| Share-based Payment Arrangement, Expense | $17.4m | $19.3m | $23.3m | $26.5m | $27.2m | $30.9m | $37.8m | $43.8m | $99.2m | $16.7m | |
| Equity Method Investment, Other than Temporary Impairment | $5.3m | $0 | $0 | — | — | — | — | — | — | — | |
| Gain (Loss) on Disposition of Assets | — | — | — | — | — | — | ($2.7m) | ($57k) | $1.1m | ($8k) | |
| Gain (Loss) on Disposition of Business | — | — | — | $6.3m | $22.6m | $2.4m | $2.7m | $57k | — | — | |
| Gain (Loss) on Extinguishment of Debt | ($11.6m) | ($19.7m) | ($14.2m) | ($38.1m) | $0 | $0 | $0 | ($14.7m) | ($28.8m) | $0 | |
| Income (Loss) from Equity Method Investments | $19.9m | $21.1m | $21.9m | $25.0m | $29.4m | $44.4m | $26.4m | $40.8m | $60.2m | $54.5m | |
| Income Tax Expense (Benefit) | $55.5m | ($18.2m) | $58.6m | $63.7m | $111.9m | $129.8m | $62.6m | $82.6m | $44.8m | $58.2m | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $128.6m | $117.9m | |
| Earnings (Loss)es From Equity Investments | — | — | — | — | — | — | ($26.4m) | ($40.8m) | ($60.2m) | ($54.5m) | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | $39.3m | $197.2m | ($54.6m) | $58.0m | $116.6m | ($23.1m) | $52.2m | ($1.2m) | $95.8m | $45.2m | |
| Increase (Decrease) in Accounts Payable | ($15.5m) | $3.9m | ($1.8m) | $5.7m | $27.3m | $53.4m | ($48.0m) | ($6.4m) | ($16.8m) | ($854k) | |
| Proceeds from Stock Options Exercised | $1.7m | $2.0m | $1.7m | $964k | $0 | $0 | — | — | — | — | |
| Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | $35.6m | — | $8.6m | $6.5m | $12.4m | $2.2m | $0 | $0 | ($1.1m) | $8k | |
| General and Administrative Expense | $106.9m | $114.0m | $121.3m | $128.5m | $138.0m | $147.0m | $153.0m | $170.2m | $225.9m | $154.4m | |
| Goodwill | $2.8b | $2.8b | $3.3b | $3.4b | $3.4b | $3.4b | $3.5b | $3.5b | $2.3b | $2.4b | |
| Beginning Cash Position | — | — | — | — | — | — | $74.3m | $97.9m | $84.0m | $59.7m | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | ($34.9m) | ($327.5m) | ($311.2m) | ($163.2m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($226.3m) | ($268.5m) | ($231.0m) | ($216.5m) | |
| Change In Account Payable | — | — | — | — | — | — | ($48.0m) | ($6.4m) | ($16.8m) | ($854k) | |
| Change In Accrued Expense | — | — | — | — | — | — | $12.9m | $84.1m | $26.5m | ($5.2m) | |
| Change In Other Current Assets | — | — | — | — | — | — | $11.6m | ($19.3m) | $31.0m | ($8.4m) | |
| Change In Other Working Capital | — | — | — | — | — | ($323.7m) | ($83.8m) | — | — | — | |
| Change In Payable | — | — | — | — | — | — | ($48.0m) | ($6.4m) | ($16.8m) | ($854k) | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | ($35.2m) | $77.7m | $9.7m | ($6.1m) | |
| Change In Receivables | — | — | — | — | — | — | ($52.2m) | $1.2m | ($95.8m) | ($45.2m) | |
| Change In Working Capital | — | — | — | — | — | — | ($159.5m) | $59.5m | ($55.1m) | ($59.7m) | |
| Changes In Account Receivables | — | — | — | — | — | — | ($52.2m) | $1.2m | ($95.8m) | ($45.2m) | |
| Changes In Cash | — | — | — | — | — | — | $23.6m | ($13.9m) | ($24.3m) | ($33.2m) | |
| End Cash Position | — | — | — | — | — | — | $97.9m | $84.0m | $59.7m | $26.5m | |
| Financing Cash Flow | — | — | — | — | — | — | ($34.9m) | ($327.5m) | ($311.2m) | ($163.2m) | |
| Free Cash Flow | — | — | — | — | — | — | $94.5m | $352.9m | $295.7m | $117.2m | |
| Investing Cash Flow | — | — | — | — | — | — | ($226.3m) | ($268.5m) | ($231.0m) | ($216.5m) | |
| Issuance Of Capital Stock | — | — | — | — | — | — | $0 | $0 | $511.2m | $0 | |
| Net Business Purchase And Sale | — | — | — | — | — | — | ($44.3m) | ($39.4m) | ($13.1m) | ($10.7m) | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | ($190.4m) | ($229.2m) | ($222.2m) | ($229.2m) | |
| Operating Gains Losses | — | — | — | — | — | — | ($29.1m) | ($40.7m) | ($42.3m) | ($54.5m) | |
| Other Non Cash Items | — | — | — | — | — | — | $2.3m | $2.6m | $3.0m | $3.1m | |
| Provisionand Write Offof Assets | — | — | — | — | — | — | $174k | $1.0m | $4.3m | $2.4m | |
| Purchase Of Business | — | — | — | — | — | — | ($44.3m) | ($39.4m) | ($13.1m) | ($10.7m) | |
| Purchase Of PPE | $161.6m | $233.2m | $167.3m | $157.1m | $146.4m | $180.5m | ($190.4m) | ($229.2m) | ($222.2m) | ($229.2m) | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | ($195.5m) | ($12.8m) | ($37.9m) | ($100.1m) | |
| Stock Based Compensation | — | — | — | — | — | — | $37.8m | $43.8m | $100.7m | $16.7m | |
| Other Operating Income (Expense), Net | — | — | — | — | $90.0m | $144.0m | $28.8m | $1.8m | $3.4m | $1.6m | |
| Net Cash Provided by (Used in) Operating Activities | $346.6m | $238.1m | $494.2m | $445.2m | $1.0b | $401.2m | $284.8m | $582.1m | $517.9m | $346.5m | |
| Cash flows from investing activities: | |||||||||||
| Capital Expenditure | — | — | — | — | — | — | ($190.4m) | ($229.2m) | ($222.2m) | ($229.2m) | |
| Payments to Acquire Businesses, Net of Cash Acquired | $472.2m | $27.4m | $523.1m | $93.7m | $20.8m | $81.9m | $27.0m | $29.6m | $13.1m | $9.2m | |
| Net Other Investing Changes | — | — | — | — | — | — | $8.3m | $163k | $4.3m | $23.4m | |
| Net Cash Provided by (Used in) Investing Activities | ($554.3m) | ($193.0m) | ($697.1m) | ($316.7m) | ($115.4m) | ($256.6m) | ($226.3m) | ($268.5m) | ($231.0m) | ($216.5m) | |
| Cash flows from financing activities: | |||||||||||
| Issuance Of Debt | — | — | — | — | — | — | $1.1b | $3.0b | $4.3b | $1.4b | |
| Long Term Debt Issuance | — | — | — | — | — | — | $1.1b | $3.0b | $4.3b | $1.4b | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | $264.7m | ($204.0m) | ($493.5m) | $42.3m | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | $275.1m | ($202.3m) | ($489.0m) | $51.4m | |
| Net Short Term Debt Issuance | — | — | — | — | — | — | ($10.4m) | ($1.7m) | ($4.5m) | ($9.1m) | |
| Short Term Debt Issuance | — | — | — | — | — | $42.4m | $1.1b | — | — | — | |
| Long Term Debt Payments | — | — | — | — | — | — | ($870.6m) | ($3.2b) | ($4.8b) | ($1.3b) | |
| Repayment Of Debt | — | — | — | — | — | — | ($881.0m) | ($3.2b) | ($4.8b) | ($1.3b) | |
| Short Term Debt Payments | — | — | — | — | — | — | ($10.4m) | ($1.7m) | ($4.5m) | ($9.1m) | |
| Common Stock Issuance | — | — | — | — | — | — | $0 | $0 | $511.2m | $0 | |
| Net Common Stock Issuance | — | — | — | — | — | — | ($195.5m) | ($12.8m) | $473.3m | ($100.1m) | |
| Payments of Ordinary Dividends, Common Stock | — | $0 | — | — | — | $50.6m | $64.6m | $63.9m | $64.6m | $31.4m | |
| Common Stock Payments | — | — | — | — | — | — | ($195.5m) | ($12.8m) | ($37.9m) | ($100.1m) | |
| Proceeds from Noncontrolling Interests | $11.8m | $10.0m | $2.9m | $18.4m | $7.6m | $20.7m | $9.5m | $22.9m | $15.7m | $15.9m | |
| Proceeds from (Payments to) Noncontrolling Interests | $11.8m | $10.0m | $2.9m | $18.4m | $7.6m | $20.7m | $9.5m | $22.9m | $15.7m | $15.9m | |
| Cash Dividends Paid | — | — | — | — | — | — | ($64.6m) | ($63.9m) | ($64.6m) | ($31.4m) | |
| Common Stock Dividend Paid | — | — | — | — | — | — | ($64.6m) | ($63.9m) | ($64.6m) | ($31.4m) | |
| Dividend Received CFO | — | — | — | — | — | — | $21.9m | $23.4m | $39.2m | $53.0m | |
| Net Other Financing Charges | — | — | — | — | — | — | ($39.5m) | ($46.9m) | ($226.4m) | ($74.0m) | |
| Net Cash Provided by (Used in) Financing Activities | $292.3m | ($21.6m) | $255.6m | $32.3m | ($671.5m) | ($647.4m) | ($34.9m) | ($327.5m) | ($311.2m) | ($163.2m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | $23.5m | $52.6m | $160.7m | $241.2m | ($502.8m) | $23.6m | ($13.9m) | ($24.3m) | ($33.2m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $335.9m | $577.1m | $74.3m | $97.9m | $84.0m | $59.7m | $26.5m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | $23.6m | ($13.9m) | ($24.3m) | ($33.2m) | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $142.6m | $149.2m | $193.4m | $183.0m | $155.2m | $132.2m | $183.5m | $272.3m | $256.2m | $120.6m | |
| Income Taxes Paid, Net | $70.8m | $65.0m | $48.2m | $70.6m | $108.9m | $181.2m | $32.3m | $88.5m | $133.2m | $26.0m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.